REFERENCES
- Yeung MC, Kwong KL, Wong YC, Wong SN. Paediatric Tolosa-Hunt Syndrome. J Paediatric Child Health 2004 Jul;40(7):410–413.
- La Mantia L, Curone M, Rapoport AM, Bussone G. Tolosa-Hunt Syndrome: Critical literature review based on IHS 2004 criteria. Cephalalgia 2007 Aug;27(8):960.
- Ganesan V, Lin J, Chong W, Kirkham F, Surtees R. Painful and painless ophthalmoplegia with cavernous sinus pseudotumour. Arch Dis Childhood 1996 Sep;75(3):239–41.
- Kline LB, Hoyt WF. The Tolosa-Hunt Syndrome. J Neurol Neurosurg Psychiatry 2001 Nov;71(5):577–582.
- Schuknecht B, Sturm V, Huisman TA, Landau K. Tolosa-Hunt Syndrome: MR imaging features in 15 patients with 20 episodes of painful ophthalmoplegia. Eur J Radiol 2007 Dec 29.
- Jimenez-Caballero PE, Florensa J, Marsal-Alonso C, Alavez-Tejerina A. Recurrent Tolosa-Hunt syndrome with normal neuroimaging. A report of three cases. Rev Neurol 2005 Jul 1-15;41(1):30–3
- Cakirer S. MRI findings in Tolosa-Hunt Syndrome before and after systemic corticosteroid therapy. Eur J Radiol. 2003 Feb;45(2):83–90.
- Carrilho PE, Yamamoto FI, Scaff M. Tolosa-Hunt Syndrome. Troubles in diagnosis and pattern of response to prednisone. Arq Neuropsiquiatr. 1997 Mar;55(1):101–5.
- Jimenez-Montanes L., Martinez-Fernandez M, Elizalde-Usechi M, Lopez-Pison J. The use of corticosteroids in cryptogenic palsy of the third cranial nerves. A case report. Rev Neurol. 1999 Dec 1-15;29(11):1052–4.
- Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001 Oct;85(10):1220–4.
- Foubert-Samier A, Sibon I, Maire JP, Tison F. Long-term cure of Tolosa-Hunt syndrome after low-dose focal radiotherapy. Headache 2005 Apr;45(4):389–91.
- Absoud M, Hikmet F, Dey P, Joffe M, Thambapillai E. Bilateral cavernous sinus thrombosis complicating sinusitis. J R SocMed 2006 Sep;99(9):474–6.
- Fadil H, Gonzalez-Toledo E, Kelley RE, Henley J. Wegener’s granulomatosis with extension to the cavernous sinus. J La State Med Soc. 2007 Jul-Aug;159(4):212–4.